Section Arrow
ARAY.NASDAQ
- Accuray
Quotes are at least 15-min delayed:2024/05/02 00:21 EDT
Last
 2.17
+0.04 (+1.88%)
Day High 
2.21 
Prev. Close
2.13 
1-M High
2.52 
Volume 
626.66K 
Bid
1.9
Ask
1.95
Day Low
2.14 
Open
2.15 
1-M Low
2.1 
Market Cap 
211.23M 
Currency USD 
P/E -- 
%Yield
10-SMA 2.19 
20-SMA 2.27 
50-SMA 2.47 
52-W High 4.299 
52-W Low 2.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.15/0.10
Enterprise Value
406.39M
Balance Sheet
Book Value Per Share
0.48
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
447.61M
Operating Revenue Per Share
4.59
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SINTSiNtx Technologies0.04665+0.00125+2.75%-- 
PACBPacific Biosciences of California1.685+0.035+2.12%-- 
BSXBoston Scientific Corp72.21+0.34+0.47%67.17PE
MDTMedtronic plc80.89+0.65+0.81%25.47PE
TMDXTransMedics Group117.59+23.46+24.92%-- 
Quotes are at least 15-min delayed:2024/05/02 00:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure,enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.